» Articles » PMID: 39149168

Peptain-1 Blocks Ischemia/reperfusion-induced Retinal Capillary Degeneration in Mice

Overview
Specialty Cell Biology
Date 2024 Aug 16
PMID 39149168
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Neurovascular degeneration results in vascular dysfunction, leakage, ischemia, and structural changes that can lead to significant visual impairment. We previously showed the protective effects of peptain-1, a 20 amino acid peptide derived from the αB-crystallin core domain, on retinal ganglion cells in two animal models of glaucoma. Here, we evaluated the ability of peptain-1 to block apoptosis of human retinal endothelial cells (HRECs) and retinal capillary degeneration in mice subjected to retinal ischemia/reperfusion (I/R) injury.

Methods: HRECs were treated with either peptain-1 or scrambled peptides (200 μg/mL) for 3 h and a combination of proinflammatory cytokines (IFN-γ 20 ng/mL + TNF-α 20 ng/mL+ IL-1β 20 ng/mL) for additional 48 h. Apoptosis was measured with cleaved caspase-3 formation via western blot, and by TUNEL assay. C57BL/6J mice (12 weeks old) were subjected to I/R injury by elevating the intraocular pressure to 120 mmHg for 60 min, followed by reperfusion. Peptain-1 or scrambled peptide (0.5 μg) was intravitreally injected immediately after I/R injury and 7 days later. One microliter of PBS was injected as vehicle control, and animals were euthanized on day 14 post-I/R injury. Retinal capillary degeneration was assessed after enzyme digestion followed by periodic acid-Schiff staining.

Results: Our data showed that peptain-1 entered HRECs and blocked proinflammatory cytokine-mediated apoptosis. Intravitreally administered peptain-1 was distributed throughout the retinal vessels after 4 h. I/R injury caused retinal capillary degeneration. Unlike scrambled peptide, peptain-1 protected capillaries against I/R injury. Additionally, peptain-1 inhibited microglial activation and reduced proinflammatory cytokine levels in the retina following I/R injury.

Discussion: Our study suggests that peptain-1 could be used as a therapeutic agent to prevent capillary degeneration and neuroinflammation in retinal ischemia.

References
1.
Hammes H, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C . Pericytes and the pathogenesis of diabetic retinopathy. Diabetes. 2002; 51(10):3107-12. DOI: 10.2337/diabetes.51.10.3107. View

2.
Watson E, Grant Z, Coultas L . Endothelial cell apoptosis in angiogenesis and vessel regression. Cell Mol Life Sci. 2017; 74(24):4387-4403. PMC: 11107683. DOI: 10.1007/s00018-017-2577-y. View

3.
Nagaraj R, Nahomi R, Mueller N, Raghavan C, Ammar D, Petrash J . Therapeutic potential of α-crystallin. Biochim Biophys Acta. 2015; 1860(1 Pt B):252-7. PMC: 4591086. DOI: 10.1016/j.bbagen.2015.03.012. View

4.
Nahomi R, Palmer A, Green K, Fort P, Nagaraj R . Pro-inflammatory cytokines downregulate Hsp27 and cause apoptosis of human retinal capillary endothelial cells. Biochim Biophys Acta. 2013; 1842(2):164-74. PMC: 3905326. DOI: 10.1016/j.bbadis.2013.11.011. View

5.
Osborne N, Casson R, Wood J, Chidlow G, Graham M, Melena J . Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004; 23(1):91-147. DOI: 10.1016/j.preteyeres.2003.12.001. View